Loading...
XNAS
CHRN
Market cap58mUSD
Aug 03, Last price  
23.93USD
1D
8.62%
1Q
81.01%
Jan 2017
-97.33%
IPO
-99.35%
Name

Ekso Bionics Holdings Inc

Chart & performance

D1W1MN
XNAS:CHRN chart
P/E
—
P/S
4.54
EPS
—
Div yield, %
—
Shrs. gr., 5y
38.41%
Rev. gr., 5y
7.58%
Revenues
13m
-28.60%
2,706,0003,302,0003,302,0005,327,0008,661,00014,221,0007,353,00011,332,00013,917,0008,882,00011,246,00012,912,00018,279,00017,925,00012,799,000
Net income
-12m
L+3.22%
-15,042,000-12,292-12,292-33,769,000-19,590,000-23,470,000-29,122,000-26,992,000-12,132,000-15,825,000-9,764,000-15,080,000-15,198,000-11,330,000-11,695,000
CFO
-12m
L+19.86%
-11,992-11,992-15,007,000-18,269,000-24,997,000-31,226,000-22,165,000-15,772,000-8,755,000-11,156,000-14,688,000-12,054,000-9,846,000-11,801,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.
URL
https://ir.eksobionics.com/
IPO date
Apr 10, 2013
Employees
72
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT